Healthcare -
Biotechnology - NASDAQ - US
$ 1.16
-0.431 %
$ 1.47 M
Market Cap
-0.08
P/E
KTTA - OPERATING EXPENSES
Operating Expenses KTTA - Pasithea Therapeutics Corp.
16 M
LAST VALUE
88.33%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR